These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11377731)

  • 1. Excessive lever pressing following post-training signal attenuation in rats: a possible animal model of obsessive compulsive disorder?
    Joel D; Avisar A
    Behav Brain Res; 2001 Aug; 123(1):77-87. PubMed ID: 11377731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Compulsive' lever-pressing in rats is attenuated by the serotonin re-uptake inhibitors paroxetine and fluvoxamine but not by the tricyclic antidepressant desipramine or the anxiolytic diazepam.
    Joel D; Ben-Amir E; Doljansky J; Flaisher S
    Behav Pharmacol; 2004 May; 15(3):241-52. PubMed ID: 15187582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective alleviation of compulsive lever-pressing in rats by D1, but not D2, blockade: possible implications for the involvement of D1 receptors in obsessive-compulsive disorder.
    Joel D; Doljansky J
    Neuropsychopharmacology; 2003 Jan; 28(1):77-85. PubMed ID: 12496943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of temporary inactivation of the orbital cortex in the signal attenuation rat model of obsessive compulsive disorder.
    Joel D; Klavir O
    Behav Neurosci; 2006 Aug; 120(4):976-83. PubMed ID: 16893303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal attenuation as a rat model of obsessive compulsive disorder.
    Goltseker K; Yankelevitch-Yahav R; Albelda NS; Joel D
    J Vis Exp; 2015 Jan; (95):52287. PubMed ID: 25650700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the striatum in compulsive behavior in intact and orbitofrontal-cortex-lesioned rats: possible involvement of the serotonergic system.
    Schilman EA; Klavir O; Winter C; Sohr R; Joel D
    Neuropsychopharmacology; 2010 Mar; 35(4):1026-39. PubMed ID: 20072118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder.
    Woods A; Smith C; Szewczak M; Dunn RW; Cornfeldt M; Corbett R
    Psychopharmacology (Berl); 1993; 112(2-3):195-8. PubMed ID: 7871019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of 5-HT2A and 5-HT2C receptors in the signal attenuation rat model of obsessive-compulsive disorder.
    Flaisher-Grinberg S; Klavir O; Joel D
    Int J Neuropsychopharmacol; 2008 Sep; 11(6):811-25. PubMed ID: 18339223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain differences in 'compulsive' lever-pressing.
    Brimberg L; Flaisher-Grinberg S; Schilman EA; Joel D
    Behav Brain Res; 2007 Apr; 179(1):141-51. PubMed ID: 17320982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the orbital cortex and of the serotonergic system in a rat model of obsessive compulsive disorder.
    Joel D; Doljansky J; Roz N; Rehavi M
    Neuroscience; 2005; 130(1):25-36. PubMed ID: 15561422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the cholinergic system in the signal attenuation rat model of obsessive-compulsive disorder.
    Yankelevitch-Yahav R; Joel D
    Psychopharmacology (Berl); 2013 Nov; 230(1):37-48. PubMed ID: 23685859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of NMDA receptors in the signal attenuation rat model of obsessive-compulsive disorder.
    Albelda N; Bar-On N; Joel D
    Psychopharmacology (Berl); 2010 May; 210(1):13-24. PubMed ID: 20238210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The signal attenuation rat model of obsessive-compulsive disorder: a review.
    Joel D
    Psychopharmacology (Berl); 2006 Jul; 186(4):487-503. PubMed ID: 16718482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD): investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology.
    Tsaltas E; Kontis D; Chrysikakou S; Giannou H; Biba A; Pallidi S; Christodoulou A; Maillis A; Rabavilas A
    Biol Psychiatry; 2005 May; 57(10):1176-85. PubMed ID: 15866558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ritualistic chewing behavior induced by mCPP in the rat is an animal model of obsessive compulsive disorder.
    Kreiss DS; Coffman CF; Fiacco NR; Granger JC; Helton BM; Jackson JC; Kim LV; Mistry RS; Mizer TM; Palmer LV; Vacca JA; Winkler SS; Zimmer BA
    Pharmacol Biochem Behav; 2013 Mar; 104():119-24. PubMed ID: 23333679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Compulsive' lever pressing in rats is enhanced following lesions to the orbital cortex, but not to the basolateral nucleus of the amygdala or to the dorsal medial prefrontal cortex.
    Joel D; Doljansky J; Schiller D
    Eur J Neurosci; 2005 Apr; 21(8):2252-62. PubMed ID: 15869522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of excessive lever-pressing after post-training signal attenuation in rats by repeated administration of the D1 antagonist SCH 23390 or the D2 agonist quinpirole, but not the D1 agonist SKF 38393 or the D2 antagonist haloperidol.
    Joel D; Avisar A; Doljansky J
    Behav Neurosci; 2001 Dec; 115(6):1291-300. PubMed ID: 11770060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity.
    Sesia T; Bizup B; Grace AA
    Int J Neuropsychopharmacol; 2013 Jul; 16(6):1295-307. PubMed ID: 23360787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of dorsolateral striatum enhances sensitivity to changes in the action-outcome contingency in instrumental conditioning.
    Yin HH; Knowlton BJ; Balleine BW
    Behav Brain Res; 2006 Jan; 166(2):189-96. PubMed ID: 16153716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurosteroids modulate compulsive and persistent behavior in rodents: implications for obsessive-compulsive disorder.
    S N U; J M V; N S J; P V D
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1161-6. PubMed ID: 19549549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.